CORRECTION -- ToughBuilt Industries Announces Fourth
Record fourth quarter year revenue of $29.6 million, with 20% year-over-year growthRecord full year revenue of $94.9
Globe Newswire16-03-2023, 06:48
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51